Join a Legacy of Innovation 110 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. Under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
The position will define and oversee the translational medicine strategy for a drug program across multiple indications. The successful candidate will set goals and enumerate key scientific questions that will drive clinical development decision-making. In doing so, he or she will align closely with the Global Project Team and Global Team Leader as well as counterparts overseeing research and translational activities in the laboratories in Japan. In addition, he or she will interact with counterparts in the Companion Diagnostics group to support the program. Other responsibilities will include but not be limited to identifying and interacting with key external experts and monitoring progress toward goals of external research programs. Lastly, he or she will be responsible for constructing translational plan documents, biomarker statistical analysis plans, and aid in the construction of clinical development plans, clinical protocols, and in the submission of certain regulatory documents, as well as supporting commercial in developing a strategy including patient selection strategy.
- Develop and maintain a translational plan for the program across all indications. Define key scientific questions and steps taken to answer them.
- With the Companion Diagnostics group, develop a companion diagnostic plan for the program across all indications as needed. Choose developmental paths for the diagnostics including partnerships and external collaborations.
- Identify and interact with key external experts, defining scientific questions to be answered. Monitor progress toward goals of external research programs.
- Construct translational plan documents, biomarker statistical analysis plans, and aid in the construction of clinical development plans, clinical protocols, and in the submission of certain regulatory documents. Support commercial in developing a strategy including patient selection strategy.
- Construct and co-lead Advisory Panels at certain scientific conferences. Lead the Translational Subteam within the Global Project Team for the drug program. Present as needed at internal and external meetings.
Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education Qualifications (from an accredited college or university)
- PharmD or equivalent preferred or
- PhD or equivalent preferred or
- MD or equivalent preferred
- Postgraduate training in TA (oncology) or related specialty. preferred
- 4 or More Years of experience in translational oncology drug development at a biopharmaceutical company with MD preferred
- 7 or More Years of experience in translational oncology drug development at a biopharmaceutical company with PhD preferred
- 7 or More Years of experience in translational oncology drug development at a biopharmaceutical company with PharmD preferred
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.